COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon
Thumbnail

President Trump says he is taking hydroxychloroquine to prevent COVID-19 infection

The news came just weeks after the FDA warned against treating COVID-19 with hydroxychloroquine “outside of the hospital setting or a clinical trial” due to significant cardiovascular complications.

Thumbnail

Association of Black Cardiologists shares COVID-19 resources for patients, providers

The Association of Black Cardiologists (ABC) has shared resources for patients and healthcare providers focused on COVID-19’s impact on black communities and other underserved patient populations.

Thumbnail

When patients can safely resume exercising after a COVID-19 diagnosis

As COVID-19 patients begin to bounce back, they are sure to have plenty of important questions about the recovery process. 

Thumbnail

COVID-19 especially harmful for heart transplant recipients

Heart transplant (HT) recipients have an increased risk of experiencing severe complications if infected with COVID-19, according to new findings published in JAMA Cardiology.

Thumbnail

FDA clears Philips imaging solutions for management of cardiac, lung complications related to COVID-19

Royal Philips announced Wednesday, May 13, that its ultrasound imaging solutions have been cleared by the FDA for the management of cardiac and lung complications associated with COVID-19.

Thumbnail

ACC updates data registries to track COVID-19’s impact on heart disease patients

The American College of Cardiology announced Monday, May 11, that it will start using two data registries to track and study the relationship between COVID-19 and heart disease.

Thumbnail

Latest study suggests hydroxychloroquine makes minimal impact as COVID-19 treatment

The potential use of hydroxychloroquine to treat COVID-19 has been one of the biggest stories of the current pandemic.

Thumbnail

Should cardiologists expect a rise in COVID-19 cases? Late May could bring return of ‘crippling patient surges’

Dozens of states have already announced plans to lift stay-at-home orders first put in place to slow the spread of COVID-19. How is that move expected to impact the number of new cases and deaths throughout the United States?

Displaying 369 - 376 of 427

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.